All In Biotech

Drug Trial Radar · NCT01600521

A Clinical Study of a Natural Remedy for Rheumatoid Arthritis vs. Commonly Used Conventional Medications

Last checked: Nov 20, 2026Latest source record: Apr 8, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,748 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,748

Actual

Start

Nov 2004

Primary completion

Apr 2011

Study completion Mar 2012

Sponsor

Lead sponsor
University of MinnesotaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 17, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of a combined therapy for rheumatoid arthritis (RA). The combined therapy contained paeoniflorin (Brand name: Pafulin), which has anti-inflammation properties, and Cervus and Cucumis polypeptide injection (Brand name: Songmeile), which has bone healing, pain relieving, and anti-inflammation properties. The hypothesis is that this remedy, which has long been used by the world's largest RA community, is effective and safe when tested by modern clinical standards and criteria.

Conditions

  • Rheumatoid Arthritis

Interventions

  • A Natural Remedy for Rheumatoid Arthritis vs. Common DrugsDrug

    The comparisons of the efficacy and safety of the following treatments for rheumatoid arthritis: paeoniflorin (PAE) + Cervus and Cucumis polypeptide injection (CCPI), methotrexate (MTX) + leflunomide (LEF), and MTX + LEF + CCPI.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The relief of rheumatoid arthritis symptoms and the improvement of functions assessed by the American College of Rheumatology (ACR) core set measures.Time frame: CCPI: 2 weeks + 2 weeks with 1 week in between. All other drugs: at least 12 months.

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Friendship Hospital, Affiliated to Capital Medical University

    Beijing, China

  • Institute of Chinese Medical Sciences, University of Macau

    Taipa, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.